Hemispherx Biopharma Stockholders Approve Reverse Stock Split – Yahoo Finance
Hemispherx Biopharma Stockholders Approve Reverse Stock Split Yahoo Finance Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple … … Continue reading →
Hemispherx Biopharma Stockholders Approve Reverse Stock Split – Yahoo Finance Read More »